Dengue: A reemerging concern for travelers

Cleveland Clinic Journal of Medicine

Volumn 79, Issue 7, 2012, Pages 474-482

  Hynes, Noreen A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

And DENV 4.; Dengue results from infection with one of four distinct serotypes: DENV 1; Denv 2; Denv 3

Indexed keywords

DENGUE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; EPIDEMIC; FEVER; HUMAN; INFECTION CONTROL; REVIEW; TRAVEL; UNITED STATES;

DENGUE; DIAGNOSIS, DIFFERENTIAL; DISEASE NOTIFICATION; EPIDEMICS; FEVER; HUMANS; TRAVEL; UNITED STATES;

EID: 84864000179     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.79a.11048     Document Type: Review

References (56)

1. Leggat PA. Assessment of febrile illness in the returned traveller. Aust Fam Physician 2007; 36:328-332.
2. Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med 2005; 353:924-932.
3. Mohammed HP, Ramos MM, Rivera A, et al. Travel-associated dengue infections in the United States, 1996 to 2005. J Travel Med 2010; 17:8-14.
4. Centers for Disease Control and Prevention (CDC). Travel-associated dengue surveillance-United States, 2006-2008. MMWR Morb Mortal Wkly Rep 2010; 59:715-719.
5. Ang KT, Rohani I, Look CH. Role of primary care providers in dengue prevention and control in the community. Med J Malaysia 2010; 65:58-62.
6. Centers for Disease Control and Prevention. Notice to readers: Changes to the national notifiable infectious disease list and data presentation-January 2010. MMWR Morb Mortal Wkly Rep 2010; 59:11. www.cdc.gov/mmwr/preview/mmwrhtml/mm5901a7.htm. Accessed May 29, 2012.
7. Guzman A, Istúriz RE. Update on the global spread of dengue. Int J Antimicrob Agents 2010; 36:(suppl 1):S40-S42.
8. Midgley CM, Bajwa-Joseph M, Vasanawathana S, et al. An in-depth analysis of original antigenic sin in dengue virus infection. J Virol 2011; 85:410-421.
9. Gubler DJ. Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp 2006; 277:3-16.
10. Franco L, Di Caro A, Carletti F, et al. Recent expansion of dengue virus serotype 3 in West Africa. Euro Surveill 2010; 15:19490.
11. San Martín JL, Brathwaite O, Zambrano B, et al. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am J Trop Med Hyg 2010; 82:128-135.
12. Ramos MM, Mohammed H, Zielinski-Gutierrez E, et al Dengue Serosurvey Working Group. Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a householdbased seroepidemiologic survey, December 2005. Am J Trop Med Hyg 2008; 78:364-369.
13. Ong DQ, Sitaram N, Rajakulendran M, et al. Knowledge and practice of household mosquito breeding control measures between a dengue hotspot and non-hotspot in Singapore. Ann Acad Med Singapore 2010; 39:146-149.
14. Vazquez-Prokopec GM, Chaves LF, Ritchie SA, Davis J, Kitron U. Unforeseen costs of cutting mosquito surveillance budgets. PLoS Negl Trop Dis 2010; 4:e858.
15. Ballenger-Browning KK, Elder JP. Multi-modal Aedes aegypti mosquito reduction interventions and dengue fever prevention. Trop Med Int Health 2009; 14:1542-1551.
16. Courtney M, Shetty AK. Imported dengue fever: an important reemerging disease. Pediatr Emerg Care 2009; 25:769-772.
17. Morens DM, Fauci AS. Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA 2008; 299:214- 216.
18. Gregory CJ, Santiago LM, Argüello DF, Hunsperger E, Tomashek KM. Clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic area-Puerto Rico, 2007-2008. Am J Trop Med Hyg 2010; 82:922-929.
19. Mohammed H, Ramos M, Armstrong J, et al. An outbreak of dengue fever in St. Croix (US Virgin Islands), 2005. PLoS One 2010; 5):e13729.
20. Li DS, Liu W, Guigon A, Mostyn C, Grant R, Aaskov J. Rapid displacement of dengue virus type 1 by type 4, Pacific region, 2007-2009. Emerg Infect Dis 2010; 16:123-125.
21. Hayden MH, Uejio CK, Walker K, et al. Microclimate and human factors in the divergent ecology of Aedes aegypti along the Arizona, US/Sonora, MX border. Ecohealth 2010; 7:64-77.
22. Knudsen AB. The significance of the introduction of Aedes albopictus into the southeastern United States with implications for the Caribbean, and perspectives of the Pan American Health Organization. J Am Mosq Control Assoc 1986; 2:420-423.
23. Gratz NG. Critical review of the vector status of Aedes albopictus. Med Vet Entomol 2004; 18:215-227.
24. Franco C, Hynes NA, Bouri N, Henderson DA. The dengue threat to the United States. Biosecur Bioterror 2010; 8:273-276.
25. Centers for Disease Control and Prevention (CDC). Dengue hemor rhagic fever-US-Mexico border, 2005. MMWR Morb Mortal Wkly Rep 2007; 56:785-789.
26. Brunkard JM, Robles López JL, Ramirez J, et al. Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004. Emerg Infect Dis 2007; 13:1477-1483.
27. Hafkin B, Kaplan JE, Reed C, et al. Reintroduction of dengue fever into the continental United States. I. Dengue surveillance in Texas, 1980. Am J Trop Med Hyg 1982; 31:1222-1228.
28. Centers for Disease Control and Prevention (CDC). Locally acquired Dengue-Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep 2010; 59:577-581.
29. Gill J, Stark LM, Clark GG. Dengue surveillance in Florida, 1997-98. Emerg Infect Dis 2000; 6:30-35.
30. Department of Health. DOH investigates cases of dengue fever on Oahu and asks public & community to be vigilant. http://hawaii.gov/health/about/pr/2011/11-028.pdf. Accessed May 29, 2012.
31. Wilder-Smith A, Earnest A, Tan SB, Ooi EE, Gubler DJ. Lack of association of dengue activity with haze. Epidemiol Infect 2010; 138:962-967.
32. Kyle JL, Harris E. Global spread and persistence of dengue. Annu Rev Microbiol 2008; 62:71-92.
33. Chrispal A, Boorugu H, Gopinath KG, et al. Acute undifferentiated febrile illness in adult hospitalized patients: the disease spectrum and diagnostic predictors-an experience from a tertiary care hospital in South India. Trop Doct 2010; 40:230-234.
34. World Health Organization; the Special Programme for Research and Training in Tropical Diseases (TDR). Dengue: guidelines for diagnosis, treatment, prevention and control. www.who.int/rpc/ guidelines/9789241547871/en/. Accessed May 29, 2012.
35. Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Health 2008; 13:1328-1340.
36. Streit JA, Yang M, Cavanaugh JE, Polgreen PM. Upward trend in dengue incidence among hospitalized patients, United States. Emerg Infect Dis 2011; 17:914-916.
37. Jelinek T. Dengue fever in international travelers. Clin Infect Dis 2000; 31:144-147.
38. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ 2002; 324:1563-1566.
39. Gibbons RV. Dengue conundrums. Int J Antimicrob Agents 2010; 36(suppl 1):S36-S39.
40. Halstead SB. Dengue. Lancet 2007; 370:1644-1652.
41. Halstead SB. Antibodies determine virulence in dengue. Ann N Y Acad Sci 2009; 1171(suppl 1):E48-E56.
42. Coffey LL, Mertens E, Brehin AC, et al. Human genetic determinants of dengue virus susceptibility. Microbes Infect 2009; 11:143-156.
43. García G, Sierra B, Pérez AB, et al. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am J Trop Med Hyg 2010; 82:1153-1156.
44. Braga C, Luna CF, Martelli CM, et al. Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Trop 2010; 113:234-240.
45. Jain A, Chaturvedi UC. Dengue in infants: an overview. FEMS Immunol Med Microbiol 2010; 59:119-130.
46. Almas A, Parkash O, Akhter J. Clinical factors associated with mortality in dengue infection at a tertiary care center. Southeast Asian J Trop Med Public Health 2010; 41:333-340.
47. Diaz-Quijano FA, Villar-Centeno LA, Martinez-Vega RA. Predictors of spontaneous bleeding in patients with acute febrile syndrome from a dengue endemic area. J Clin Virol 2010; 49:11-15.
48. Marón GM, Clará AW, Diddle JW, et al. Association between nutritional status and severity of dengue infection in children in El Salvador. Am J Trop Med Hyg 2010; 82:324-329.
49. Sierra B, Perez AB, Vogt K, et al. Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation? Cell Immunol 2010; 262:134-140.
50. Brien JD, Austin SK, Sukupolvi-Petty S, et al. Genotype-specific neutralization and protection by antibodies against dengue virus type J Virol 2010; 84:10630-10643.
51. Humayoun MA, Waseem T, Jawa AA, Hashmi MS, Akram J. Multiple dengue serotypes and high frequency of dengue hemorrhagic fever at two tertiary care hospitals in Lahore during the 2008 dengue virus outbreak in Punjab, Pakistan. Int J Infect Dis 2010; 14(suppl 3):e54-e59.
52. Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nature Rev Microbiol 2010; 8:S7-S16.
53. Crowell CS, Stamos JK. Evaluation of fever after international travel. Pediatr Ann 2011; 40:39-44.
54. Durbin AP, Whitehead SS. Dengue vaccine candidates in development. Curr Top Microbiol Immunol 2010; 338:129-143.
55. Chen LH, Wilson ME. Dengue and chikungunya infections in travelers. Curr Opin Infect Dis 2010; 23:438-444.
56. Lambrechts L, Scott TW, Gubler DJ. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis 2010; 4:e646.